Table of Contents
Print

How do structural brain changes relate to ADHD genotypes? 

ADHD brain structure genetics is a growing field that seeks to connect the structural brain changes seen in individuals with ADHD to their genotypes, the genetic makeup that influences the development and function of the brain. Research has shown that ADHD is not only influenced by genetics but also by structural brain differences, particularly in areas involved in attention, impulse control, and executive function. 

Understanding how specific genetic variants contribute to these brain changes can offer deeper insights into the heritability of ADHD and its biological foundations. 

How ADHD genotypes affect brain structure 

ADHD genotypes affect brain structure by influencing the development and connectivity of regions involved in attention, impulse control, and reward processing. 

Cortical volume and ADHD  

One of the most prominent findings in brain structure studies of ADHD is reduced cortical volume, particularly in the prefrontal cortex and parietal cortex, which are involved in decision-making, attention, and working memory. These areas are crucial for executive function, which is often impaired in ADHD. 

Genetic variants 

In genes like DRD4 (dopamine receptor) and DAT1 (dopamine transporter) have been linked to reduced cortical volume. These genes are involved in dopamine regulation, which is key to neural function and brain development. Reduced dopamine signalling could affect the growth and maturation of cortical regions. 

Grey matter differences 

Studies have shown that individuals with ADHD often have reduced grey matter in regions like the prefrontal cortex, striatum, and cingulate cortex. These areas are critical for attention, impulse control, and reward processing. Heritability studies suggest that these structural differences are partly genetic, with some genetic variants influencing how grey matter develops. 

The COMT gene, which is involved in dopamine breakdown, is one of the key genetic variants linked to grey matter differences. Variations in COMT can lead to altered dopamine levels, which may contribute to the grey matter reductions seen in ADHD. 

How structural brain changes reflect ADHD heritability 

Genetic contribution to brain structure Brain imaging studies, including MRI scans, have shown that many of the structural changes associated with ADHD have a genetic basis. Heritability estimates for ADHD range from 70–80%, meaning that most of the variation in ADHD is due to genetic factors, including those that influence brain structure. 

Genetic studies have found that certain variants in genes related to dopamine regulation, synaptic plasticity, and neurodevelopment are associated with changes in brain volume and the development of specific brain regions involved in ADHD symptoms. 

Gene-environment interaction 

While genetics play a significant role, environmental factors such as prenatal exposure to toxins, stress, and nutrition also influence brain development and the manifestation of ADHD. The interaction between genes and environment can further shape the brain’s structure and influence ADHD symptoms. 

Why this connection matters for ADHD treatment 

This connection matters for ADHD treatment because understanding how genetics shape brain structure can guide more precise, personalised interventions and medication choices. 

Personalising ADHD treatment  

Understanding how ADHD genotypes influence brain structure can help create more personalised treatments. For instance, knowing that a child’s ADHD is linked to certain structural brain changes could influence the choice of medication or therapeutic intervention, as some treatments may better address specific neural deficits. 

Targeted therapies for brain structure 

 As our understanding of brain structure genetics improves, future therapies may focus not just on symptom management, but also on promoting brain growth and plasticity in affected areas. This could include neurofeedback or cognitive training that targets specific brain regions, helping to strengthen areas of the brain involved in attention and executive function. 

Long-term outcomes and prevention  

Early identification of structural brain differences and genetic risk factors could lead to earlier interventions, potentially improving long-term outcomes. By understanding the genetic basis for brain structure differences, it may be possible to prevent or mitigate some of the developmental challenges associated with ADHD. 

ADHD brain structure genetics is opening new possibilities for more targeted, personalised treatments based on an individual’s brain development and genetic profile. By linking genetic variants to cortical volume and grey matter differences, researchers are paving the way for more effective ADHD care that addresses both the biological and genetic components of the disorder. 

Visit providers like ADHD Certify for personal consultations that explore how genetics and brain structure influence ADHD.  

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.